Jazz Pharmaceuticals
JAZZ
#1899
Rank
NZ$17.84 B
Marketcap
NZ$293.75
Share price
1.67%
Change (1 day)
39.91%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -NZ$1.15 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are NZ$4.15 Billion. In 2024 the company made an earning of NZ$0.81 Billion, an increase over its 2023 earnings that were of NZ$0.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$1.15 Billion-241.15%
2024 NZ$0.81 B57.87%
2023 NZ$0.51 B-179.92%
2022 -NZ$0.65 Billion230.37%
2021 -NZ$0.2 Billion-141.02%
2020 NZ$0.47 B-39.45%
2019 NZ$0.78 B-14.2%
2018 NZ$0.91 B20.03%
2017 NZ$0.76 B-17.15%
2016 NZ$0.92 B22.14%
2015 NZ$0.75 B187.64%
2014 NZ$0.26 B-50.79%
2013 NZ$0.53 B73.63%
2012 NZ$0.30 B41.69%
2011 NZ$0.21 B116.61%
2010 NZ$0.10 B262.77%
2009 NZ$27.57 M-111.33%
2008 -NZ$0.25 Billion1.31%
2007 -NZ$0.25 Billion77.8%
2006 -NZ$0.14 Billion36.59%
2005 -NZ$98.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Endo International
ENDPQ
-NZ$4.15 Billion 240.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
NZ$3.62 B-398.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.42 B-2,435.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
NZ$3.06 B-352.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel